[OncoHost in DocWire News] OncoHost develops predictive biomarker for irAEs in non-small cell lung cancer
Lung Cancers Today spoke with Dr. Ofer Sharon, CEO of OncoHost, to discuss the lack of dependable pre-treatment biomarkers for predicting irAE development and how OncoHost is spearheading the efforts to address this issue. Watch...
Read More